Fetal Aberrant Right Subclavian Artery: Associated Anomalies, Genetic Etiology, and Postnatal Outcomes in a Retrospective Cohort Study
Open Access
- 3 June 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 10, 895562
Abstract
Background: Aberrant right subclavian artery (ARSA) is becoming increasingly common in fetuses. However, there are relatively fewer studies regarding the genetic etiology of ARSA. We performed a genetic analysis of fetuses with ARSA and followed up on the pregnancy outcomes to evaluate the prognosis of the fetuses, providing information for prenatal and eugenic consultations.Methods: This retrospective study included 112 pregnant females whose fetuses were diagnosed with ARSA from December 2016 to February 2021. Fetal karyotype analysis and single-nucleotide polymorphism (SNP) array were performed.Results: The 112 fetuses were divided into two groups: the isolated ARSA group (n = 48, 42.9%) and the non-isolated ARSA group (ARSA with other ultrasound abnormalities, n = 64, 57.1%). The total rate of pathogenic copy number variation (CNV) observed using karyotype analysis (3/8) and SNP array (5/8) was 7.1% (8/112). The rates of pathogenic CNV in the isolated and non-isolated ARSA groups were 4.2% (2/48) and 9.4% (6/64), respectively. No significant difference was observed between the two groups (P = 0.463). The results of genetic analysis influenced the parents’ decision to terminate the pregnancy. During the follow-up examination, fetuses with ARSA without pathogenic CNV were found to have normal growth and development after birth.Conclusion: Fetuses with isolated ARSA have a low probability of being diagnosed with pathogenic CNV. However, when ARSA is complicated with other ultrasound abnormalities, the risk of pathogenic CNV remarkably increases. Prenatal genetic counseling and SNP-array should be recommended for better assessment of fetal prognosis.Keywords
All Related Versions
This publication has 43 references indexed in Scilit:
- Aberrant right subclavian artery in Down syndrome fetusesPrenatal Diagnosis, 2013
- Chromosomal Microarray versus Karyotyping for Prenatal DiagnosisNew England Journal of Medicine, 2012
- Aberrant right subclavian artery (ARSA) in unselected population at first and second trimester ultrasonographyPrenatal Diagnosis, 2012
- Aberrant right subclavian artery: incidence and correlation with other markers of Down syndrome in second‐trimester fetusesUltrasound in Obstetrics & Gynecology, 2011
- American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variantsGenetics in Medicine, 2011
- Aberrant right subclavian artery at 16 to 23 + 6 weeks of gestation: a marker for chromosomal abnormalityUltrasound in Obstetrics & Gynecology, 2010
- Fetal aberrant right subclavian artery in normal and Down syndrome fetusesUltrasound in Obstetrics & Gynecology, 2007
- Aortic arch with four vessels: aberrant right subclavian arteryUltrasound in Obstetrics & Gynecology, 2007
- Aberrant right subclavian artery as a new cardiac sign in second- and third-trimester fetuses with Down syndromeAmerican Journal of Obstetrics and Gynecology, 2005
- Aberrant right subclavian artery with left aortic arch: Associated cardiac anomaliesPediatric Cardiology, 1993